Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder
NCT01871974
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder Patients
Interventions
DRUG:
FK949E
Sponsor
Astellas Pharma Inc